Topical roflumilast
ARQ-151-306
Phase 3 small_molecule completed
Quick answer
Topical roflumilast for Chronic Plaque Psoriasis is a Phase 3 program (small_molecule) at Arcutis Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcutis Biotherapeutics
- Indication
- Chronic Plaque Psoriasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed